The use of the electromotive drug administration system in patients with superficial bladder cancer a review of the clinical effectiveness, safety, and cost-effectiveness
Non-muscle (superficial) invasive bladder cancer accounted for about 6% of all cancers in Canada in 2008. To treat this condition, systemic drug delivery to the bladder is generally ineffective as the bladder's wall prevents therapeutic substances from diffusing through. Intravesical therapy de...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
17 September 2014, 2014
|
| Series: | Rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references